Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2007;66(Supplement 3 ):iii23-iii28; doi:10.1136/ard.2007.079822
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism.

OPENING LECTURES

Actin cytoskeleton dynamics linked to synovial fibroblast activation as a novel pathogenic principle in TNF-driven arthritis

Y Vasilopoulos, V Gkretsi, M Armaka, V Aidinis, G Kollias

Institute of Immunology, Biomedical Sciences Research Center "Alexander Fleming", Athens, Greece

Correspondence to:
Dr G Kollias, Biomedical Sciences Research Center "Alexander Fleming", Athens, Greece; g.kollias{at}fleming.gr

Rheumatoid arthritis is a chronic inflammatory disorder whose origin of defect has been the subject of extensive research during the past few decades. While a number of immune and non-immune cell types participate in the development of chronic destructive inflammation in the arthritic joint, synovial fibroblasts have emerged as key effector cells capable of modulating both joint destruction and propagation of inflammation. Ample evidence of aberrant changes in the morphology and biochemical behaviour of rheumatoid arthritis synovial fibroblasts have established the tissue evading and "transformed" character of this cell type. We have recently demonstrated that actin cytoskeletal rearrangements determine the pathogenic activation of synovial fibroblasts in modelled TNF-mediated arthritis, a finding correlating with similar gene expression changes which we observed in human rheumatoid arthritis synovial fibroblasts. Here, we show that pharmacological inhibition of actin cytoskeleton dynamics alters potential pathogenic properties of the arthritogenic synovial fibroblast, such as proliferation, migration and resistance to apoptosis, indicating novel opportunities for therapeutic intervention in arthritis. Recent advances in this field of research are reviewed and discussed.

Abbreviations: ECM, extracellular matrix; EMT, epithelial–mesenchymal transition; Lat-A, latrunculin A; MMPs, matrix metalloproteinases; RA, rheumatoid arthritis; RASFs, rheumatoid arthritis synovial fibroblasts; SF, synovial fibroblast; SCID, severe combined immunodeficient; SRF, serum response factor; TNF{alpha}, tumour necrosis factor {alpha}; Wt, wild type


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs